期刊文献+

基质金属蛋白酶2及组织金属蛋白酶抑制剂2在大肠癌中的表达 被引量:9

EXPRESSION OF MATRIX METALLOPROTEINASE 2 AND TISSUE INHIBITOR OF METALLOPROTEINASE 2 mRNAs IN COLORECTAL NEOPLASIA
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶2(MMP2)及组织金属蛋白酶抑制剂2(TIMP2)与大肠癌的关系。方法:采用RTPCR方法对12例结肠癌、20例直肠癌(其中4例为复发癌)组织及相应正常组织中MMP2和TIMP2mRNA表达水平进行测定。结果:27/32的肿瘤组织和18/32的正常组织中有MMP2mRNA表达,TIMP2mRNA的表达比例分别为29/32和25/32。MMP2在大肠癌组织中的表达水平与患者年龄呈负相关。11例正常组织MMP2mRNA水平高于肿瘤组织水平的病例中,结肠癌的比例明显高于直肠癌(18/32,16/32,P<0.05)。结论:大肠癌不同年龄所表现的不同生物学行为可能与MMP2在肿瘤组织中的表达水平有关。 ABSTRACT Objective:To measure the expression levels of matrix metalloproteinase 2 (MMP2) and its inhibitor, tissue inhibitor of metalloproteinase 2 (TIMP2), and to discuss their relationship with the colorectal neoplasia. Methods: RTPCR technique was used to measure the levels of MMP2 mRNA and TIMP2 mRNA in 12 cases of colon carcinoma and 20 cases of rectal carcinoma (involved 4 recurrent cases). Results: The MMP2 mRNA was expressed in 27/32 tumor tissues and 18/32 normal tissues. For the TIMP2, the rates were 29/32 and 25/32, respectively. The levels of MMP2 mRNA in tumor tissues were negatively correlated with the ages of patients. Eleven cases had the higher level of MMP2 mRNA in normal tissue than in tumor tissue, and the incidence in colon carcinoma was much higher than that in rectal carcinoma (18/32,16/32,P<0.05). Conclusion: The biological behaviours of colorectal cancer changed with the ages of patients which may be correlated with the expression levels of the MMP2 in cancer tissue. The biological behaviours of the colon cancer were different from those of rectal cancer.
出处 《北京医科大学学报》 CSCD 1998年第4期326-329,共4页 Journal of Peking University(Health Sciences)
  • 相关文献

同被引文献45

  • 1李全香,郭新华.基质金属蛋白酶-2与子宫内膜异位症的相关研究[J].肿瘤防治杂志,2005,12(9):711-714. 被引量:2
  • 2蔡文琴 王伯云.免疫组织化学和核酸分子杂交技术[M].北京:人民卫生出版社,1993..
  • 3史宏男.基质金属蛋白酶在涎腺腺样囊性组织中的表达及意义[J].华西口腔医学杂志,1997,15:218-218.
  • 4李楠 徐采朴 刘为纹 等.转染金属蛋白酶抑制剂对胃癌细胞体外侵袭能力的影响[J].中国肿瘤杂志,2001,10:162-162.
  • 5[2]Hiroshi S, Yuri K, Masayoshi M, et al. Expression of genes encoding type Ⅳ eollagen-degradng metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells [ J ]. Oncogene, 1992,7:77 - 83.
  • 6Nawrockl B, Poiitte M, Marchard V, et al. Expression of matrix onclallproteinases and their inhibitors in human bronchopulmaonar, carcinomas: quantificative and morphological analyses.Int J Cancer, 1997,72:556-564.
  • 7Khokha R,Micheal B,Tsao M,et al. Expression and prognostic signficance of metallproteinases and their tissue inhibitor in patients with small cell lung cancer. J Clin Oncol, 1999,17:1802-1808.
  • 8Greene J,J Biol Chem,1996年,271卷,30375页
  • 9蔡文琴,免疫组织化学和核酸分子杂交技术,1993年
  • 10Anderson WF. Gene therapy of cancer [J]. Hum Gene Ther,1994, 5: 1-2.

引证文献9

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部